Drug sales (proportion of the cost per group) for dyspepsia, gastro-oesophageal reflux disease, and “gastritis” in Sweden in 1996; total cost US$170 million67
Percentage of cost | |
---|---|
Antacids/alginates | 6 |
H2 receptor antagonists | 21 |
Proton pump inhibitors | 67 |
Prokinetics | 6 |